Meta Pixel

News and Announcements

How To Strategize Your Capital Raise

  • Published December 14, 2022 4:00AM UTC
  • Publisher Osama Hassan
  • Categories Capital Raising Tips

Fundraising is a time sink, and while you’re out raising capital, your competitors are out hiring the best talent, winning customers, and gaining critical competitive ground.

This is why it’s critical to have a strategy in place for your capital raise.

Your fundraising strategy should be adjusted and constantly refined based on the stage of your startup, your performance, your industry, macroeconomic factors, and investor sentiment, among other factors.

Most importantly, your cap raising strategy should align with your startup’s business model and its consequent equity, debt, and working capital requirements, as well as limitations.

Here are 5 questions you can ask yourself to get started with your own strategy: 

1. How will I deploy the capital raised?

2. What is the minimum and maximum ticket size I’m willing to accept from an investor?

3. What will investors ask about most frequently? (hint: prepare an FAQ doc)

4. What kind of investors am I looking for?

5. What are investors looking for in companies they are willing to invest in?

See comments below for links to previous posts I’ve shared to help you answer questions 4 and 5.

Click here to view the original Linkedin post.

Looking for a platform to raise capital? Click here to discover how Wholesale Investor can help you.

Your capital engagement platform

With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.

Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck

Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]

Capital Insights
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.

Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation

Capital Insights
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula

Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.

Join over 45,000+ sophisticated investors

Join Now